Benefit of Tacrolimus/Myocophenolate To Reduce Cardiac Allograft Vasculopathy after Heart Transplantation

被引:0
|
作者
Patel, J. [1 ]
Kittleson, M. [1 ]
Rafiei, M. [1 ]
Osborne, A. [1 ]
Aaronson, A. [1 ]
Chang, D. H. [1 ]
Azarbal, B. [1 ]
Czer, L. [1 ]
Moriguchi, J. [1 ]
Kobashigawa, J. [1 ]
机构
[1] Cedars Sinai Heart Inst, Los Angeles, CA USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
114
引用
收藏
页码:S50 / S50
页数:1
相关论文
共 50 条
  • [11] Medication Management of Cardiac Allograft Vasculopathy After Heart Transplantation
    Hollis, Ian B.
    Reed, Brent N.
    Moranville, Michael P.
    PHARMACOTHERAPY, 2015, 35 (05): : 489 - 501
  • [12] CARDIAC ALLOGRAFT VASCULOPATHY AFTER CARDIAC TRANSPLANTATION
    WEIS, M
    HARTMANN, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (39) : 1327 - 1333
  • [13] Cardiac Rehabilitation after Heart Transplantation Reduces Development of Cardiac Allograft Vasculopathy
    Thottam, M.
    Patel, J.
    Kittleson, M.
    Rafiei, M.
    Osborne, A.
    Velleca, A.
    Piponniau, L.
    Chang, D. H.
    Czer, L.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S80 - S80
  • [14] Cardiac Allograft Vasculopathy and Survival after Heart Transplantation for Chagas' Heart Disease
    Diez, M.
    Favaloro, L.
    Bertolotti, A.
    Vigliano, C.
    Peradejordi, M.
    Schijman, A.
    Favaloro, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S32 - S33
  • [15] CARDIAC ALLOGRAFT VASCULOPATHY AND SURVIVAL AFTER HEART TRANSPLANTATION FOR CHAGAS' HEART DISEASE
    Diez, Mirta
    Favaloro, Liliana
    Bertolotti, Alejandro
    Vigliano, Carlos
    Peradejordi, Margarita
    Schijman, Alejandro
    Favaloro, Roberto
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E926 - E926
  • [16] Extracorporeal photopheresis as treatment of cardiac allograft vasculopathy after heart transplantation
    Hansen, Sandra
    Laustsen, Mira
    Staunstrup, Nicklas Heine
    Clemmensen, Tor Skibsted
    Eiskjaer, Hans
    Koefoed-Nielsen, Pernille
    HLA, 2022, 99 (05) : 458 - 458
  • [17] Cardiac allograft vasculopathy after heart transplantation: Risk factors and management
    Valantine, H
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (05): : S187 - S193
  • [18] Identification of characteristics influencing cardiac allograft vasculopathy after heart transplantation
    Grymonprez, Florence
    Timmermans, Thierry
    De Azevedo, David
    Badii, Maria
    Mastrobuoni, Stefano
    Poncelet, Alain
    Gurne, Olivier
    Pouleur, Anne-Catherine
    ACTA CARDIOLOGICA, 2023, 78 : 13 - 13
  • [19] The Role of Cardiac Rehabilitation after Heart Transplantation in the Reduction of Cardiac Allograft Vasculopathy.
    Kittleson, M.
    Patel, J.
    Rafiei, M.
    Osborne, A.
    Chang, D.
    Czer, L.
    Kobashigawa, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 452 - 452
  • [20] IDENTIFICATION AND DETERMINANTS OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) TRAJECTORIES AFTER HEART TRANSPLANTATION
    Bonnet, Guillaume
    Coutance, Guillaume
    Racape, Maud
    Raynaud, Marc
    van Keer, Jan
    Bories, Marie-Cecile
    Varnous, Shaida
    Rouvier, Philippe
    Guillemain, Romain
    Lecuyer, Lucien
    Bruneval, Patrick
    Duong-Van-Huyen, Jean-Paul
    Taupin, Jean-Luc
    Naesens, Maarten
    Lefaucheur, Carmen
    Jouven, Xavier
    Kobashigawa, Jon
    Loupy, Alexandre
    TRANSPLANT INTERNATIONAL, 2019, 32 : 391 - 391